Presentation is loading. Please wait.

Presentation is loading. Please wait.

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu,

Similar presentations


Presentation on theme: "Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu,"— Presentation transcript:

1 Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu, Xiao-Hui Zhang, Xiao Ma, Zhi-Ping Fan, De-Pei Wu, and Xiao-Jun Huang Blood Volume 125(25): June 18, 2015 ©2015 by American Society of Hematology

2 Outcomes after transplantation according to donor source.
Outcomes after transplantation according to donor source. The rate of DFS (A) and the rate of OS (B). (C) The incidence of NRM. (D) The incidence of relapse. The incidence of neutrophil engraftment (>500 neutrophils per mm3) (E) and the incidence of platelet engraftment (>20 000 platelets per cubic mm3, without platelet transfusion during the prior 7 days) (F). The incidence of acute GVHD of grades 2 to 4 (G) and the incidence of chronic GVHD (H). Yu Wang et al. Blood 2015;125: ©2015 by American Society of Hematology


Download ppt "Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu,"

Similar presentations


Ads by Google